- Health Topics
- The Science
- Grants and Training
- News and Events
- About NHLBI
All News
|
Statement
In large clinical trials conducted worldwide, full dose anti-coagulation (blood thinner) treatments given to moderately ill patients hospitalized for COVID-19 reduced the requirement of vital organ support—such as the need for mechanical ventilation. A trend in possible reduction of mortality was also observed and is being further studied. With...
Showing 10 out of 1390 results
NHLBI in the Press
Researchers are reporting a new way of analyzing genetic test data that may help identify people at high risk of heart disease and other common medical conditions.